Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Horvath, Steve ^a   Nazmul Hossain, Abu N M ^a   Pollard, Rodney P E ^b   Kroese, Frans G M ^b   Vissink, Arjan ^b   Kallenberg, Cees G M ^b   Spijkervet, Fred K L ^b   Bootsma, Hendrika ^b   Michie, Sara A ^c   Gorr, Sven U ^d   Peck, Ammon B ^e   Cai, Chaochao ^a   Zhou, Hui ^a   Wong, David T W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSCRIPTOME;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PAROTID GLAND; PATHOGENESIS; RNA ANALYSIS; SALIVARY GLAND; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; UPREGULATION; AGED; ANIMAL; C57BL MOUSE; CLUSTER ANALYSIS; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMS BIOLOGY;

ADULT; AGED; ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; MALE; MICE, INBRED C57BL; MICE, INBRED NOD; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAROTID GLAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLANDS; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; SYSTEMS BIOLOGY;

EID: 84868242084     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4081     Document Type: Article

References (36)

1. Fox R. Sjogren's syndrome. Lancet 2005, 366:321-331. 10.1016/S0140-6736(05)66990-5, 16039337.
2. Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjogren's syndrome. Oral Dis 2002, 8:130-140. 10.1034/j.1601-0825.2002.02846.x, 12108757.
3. Delaleu N, Jonsson R, Koller MM. Sjogren's syndrome. Eur J Oral Sci 2005, 113:101-113. 10.1111/j.1600-0722.2004.00183.x, 15819815.
4. Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, Bootsma H. Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology (Oxford) 2009, 48:1077-1082.
5. Pijpe J, Meijer JM, Bootsma H, van der Wal JE, Spijkervet FK, Kallenberg CG, Vissink A, Ihrler S. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjogren's syndrome. Arthritis Rheum 2009, 60:3251-3256. 10.1002/art.24903, 19877054.
6. Ramos-Casals M, Tzioufas AG, Stone JH, Siso A, Bosch X. Treatment of primary Sjogren syndrome: a systematic review. JAMA 2010, 304:452-460. 10.1001/jama.2010.1014, 20664046.
7. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558. 10.1136/ard.61.6.554, 1754137, 12006334.
8. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dorner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011, 70:968-972. 10.1136/ard.2010.143743, 21345815.
9. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010, 69:1103-1109. 10.1136/ard.2009.110619, 2937022, 19561361.
10. Mariette X, Gottenberg JE. Pathogenesis of Sjogren's syndrome and therapeutic consequences. Curr Opin Rheumatol 2010, 22:471-477. 10.1097/BOR.0b013e32833c36c5, 20671520.
11. Chiorini JA, Cihakova D, Ouellette CE, Caturegli P. Sjogren syndrome: advances in the pathogenesis from animal models. J Autoimmun 2009, 33:190-196. 10.1016/j.jaut.2009.09.009, 3439154, 19800762.
12. Delaleu N, Nguyen CQ, Peck AB, Jonsson R. Sjogren's syndrome: studying the disease in mice. Arthritis Res Ther 2011, 13:217. 10.1186/ar3313, 3218871, 21672284.
13. Hu S, Zhou M, Jiang J, Wang J, Elashoff D, Gorr S, Michie SA, Spijkervet FK, Bootsma H, Kallenberg CG, Vissink A, Horvath S, Wong DT. Systems biology analysis of Sjogren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum 2009, 60:81-92. 10.1002/art.24150, 2718690, 19116902.
14. Soyfoo MS, Steinfeld S, Delporte C. Usefulness of mouse models to study the pathogenesis of Sjogren's syndrome. Oral Dis 2007, 13:366-375. 10.1111/j.1601-0825.2007.01376.x, 17577322.
15. Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background. Arthritis Rheum 2002, 46:1390-1398. 10.1002/art.10258, 12115247.
16. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005, 4:Article17.
17. Davidoff AM, Pence JC, Shorter NA, Iglehart JD, Marks JR. Expression of p53 gene in human neuroblastoma and neuroepithelioma-derived cell lines. Oncogene 1992, 7:127-133.
18. Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, Bootsma H, Kallenberg CG, Spijkervet FK. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2007, 46:335-341.
19. R project. , http://cran.r-project.org/
20. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127. 10.1093/biostatistics/kxj037, 16632515.
21. Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, Salomon DR, Horvath S. Strategies for aggregating gene expression data: the collapseRows R function. BMC bioinformatics 2011, 12:322. 10.1186/1471-2105-12-322, 3166942, 21816037.
22. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9:559. 10.1186/1471-2105-9-559, 2631488, 19114008.
23. Mason MJ, Fan G, Plath K, Zhou Q, Horvath S. Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics 2009, 10:327. 10.1186/1471-2164-10-327, 2727539, 19619308.
24. Yip AM, Horvath S. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics 2007, 8:22. 10.1186/1471-2105-8-22, 1797055, 17250769.
25. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 2008, 24:719-720. 10.1093/bioinformatics/btm563, 18024473.
26. Horvath S, Dong J. Geometric interpretation of gene co-expression network analysis. PLoS Comput Biol 2008, 4:e1000117. 10.1371/journal.pcbi.1000117, 2446438, 18704157.
27. DAVID Bioinformatics Resources 6.7. , http://david.abcc.ncifcrf.gov/
28. Ingenuity Systems. , http://www.ingenuity.com
29. Meiners PM, Vissink A, Kallenberg CG, Kroese FG, Bootsma H. Treatment of primary Sjogren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?. Expert Opin Biol Ther 2011, 11:1381-1394. 10.1517/14712598.2011.605352, 21819314.
30. Kallenberg CG, Vissink A, Kroese FG, Abdulahad WH, Bootsma H. What have we learned from clinical trials in primary Sjogren's syndrome about pathogenesis?. Arthritis Res Ther 2011, 13:205. 10.1186/ar3234, 3157640, 21371351.
31. Hansen A, Lipsky PE, Dorner T. Immunopathogenesis of primary Sjogren's syndrome: implications for disease management and therapy. Curr Opin Rheumatol 2005, 17:558-565. 10.1097/01.bor.0000172801.56744.c3, 16093833.
32. Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P. Role of chemokines in endocrine autoimmune diseases. Endocrine Rev 2007, 28:492-520.
33. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, Febbo PG, Kornblum HI, Cloughesy TF, Nelson SF, Mischel PS. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 2006, 103:17402-17407. 10.1073/pnas.0608396103, 1635024, 17090670.
34. Langfelder P, Luo R, Oldham MC, Horvath S. Is my network module preserved and reproducible?. PLoS Comput Biol 2011, 7:e1001057. 10.1371/journal.pcbi.1001057, 3024255, 21283776.
35. Segal B, Thomas W, Rogers T, Leon JM, Hughes P, Patel D, Patel K, Novitzke J, Rohrer M, Gopalakrishnan R, Myers S, Nazmul-Hossain A, Emamian E, Huang A, Rhodus N, Moser K. Prevalence, severity, and predictors of fatigue in subjects with primary Sjogren's syndrome. Arthritis Rheum 2008, 59:1780-1787. 10.1002/art.24311, 3106978, 19035421.
36. Peck AB, Saylor BT, Nguyen L, Sharma A, She JX, Nguyen CQ, McIndoe RA. Gene expression profiling of early-phase Sjogren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes. Invest Ophthalmol Vis Sci 2011, 52:5647-5655. 10.1167/iovs.11-7652, 3176054, 21666236.